ACVC Partners

Sepion is an advanced membrane company offering a platform suite of highly-tunable nanoscale membranes for multiple industrial markets.

Debut Biotechnology, Inc. is a biotechnology company based in San Diego, California, established in 2019. It specializes in biomanufacturing solutions for high-value molecules, focusing on the development of specialty enzyme solutions and continuous manufacturing processes. The company offers a range of services, including biomanufacturing cartridges, fermentation, and the immobilization of cells and enzymes. Debut Biotechnology is dedicated to creating novel immobilization techniques for enzymes, achieving high success rates and providing immobilized enzymes for continuous manufacturing systems. Its innovative approach enables the production and modification of small and large molecules, catering primarily to the pharmaceutical and specialty chemical industries. By harnessing natural enzyme technologies, Debut aims to deliver sustainable and cost-effective ingredient solutions to its clients.

DarwinAI Corp. specializes in designing and developing a platform that generates deep neural networks for enterprise artificial intelligence applications. The company's flagship product, GenSynth, is a software platform that provides developers and data scientists with tools to accelerate the deep learning development cycle in a transparent manner. GenSynth automatically creates new models that meet specific performance targets while maintaining transparency throughout the development process, allowing users to understand the factors influencing model decisions. Founded in 2017 and headquartered in Waterloo, Canada, DarwinAI leverages patented Generative Synthesis technology to enhance the efficiency, portability, scalability, and comprehensibility of artificial intelligence, making advanced AI accessible to a broader audience.